Subjects
UNESCO::32 Medicina::3201 Ciencias clínicas::320199 Otras especialidades (Enfermería)
UNESCO::32 Medicina::3201 Ciencias clínicas::320108 Ginecología
Mastopatía fibroquística: ¿son útiles los tratamientos empleados en mujeres en etapa premenopáusica?
Abstract
Introducción: La mastopatía fibroquística es una patología que afecta cada vez a más mujeres en el mundo y, a pesar de ello, es una enfermedad muy poco conocida entre las mismas. Es muy común entre los 35-40 años y consiste en la aparición de dolor mamario (normalmente asociado al ciclo menstrual), de nódulos en la mama y puede ir acompañado de tensión mamaria. Dependiendo de las características histológicas (lesiones proliferativas con atipia, lesiones proliferativas sin atipia y lesiones no proliferativas) hay un mayor o menor riesgo de desarrollar cáncer de mama en un futuro, respectivamente. El cáncer de mama en España se considera la primera causa de muerte en mujeres y provoca 5.000 muertes al año. Hay numerosos tratamientos usados en esta patología pero de momento, no hay ninguno que cure la enfermedad, si no que se emplean para aliviar o disminuir los síntomas que produce. Los tratamientos más empleados son el Danazol, la bromocriptina y el tamoxifeno, a pesar de que provocan efectos secundarios considerables. Objetivo: determinar la utilidad de los tratamientos empleados en mujeres en etapa premenopáusica que presentan mastopatía fibroquística. Metodología: desarrollo de un proceso observacional dirigido a pacientes premenopáusicas que hayan sido diagnosticadas de MFQ. Implicaciones para la práctica de la enfermería: la enfermería debe obtener más conocimientos sobre esta patología además de conocer los tratamientos más beneficiosos para los pacientes.
Introduction: Fibrocystic mastopathy is a pathology that is transmitted more and more women in the world and, despite this, is a much unknown disease among them. It is very common between 35-40 years and it consists on the appearance of breast pain (usually associated to the menstrual cycle), nodules in the breast and it can appear breast tension. Depending on the histological characteristics (proliferative lesions with atypia, proliferative lesions without atypia and non-proliferative lesions) there is a higher or lesser risk of developing breast cancer in the future, respectively. Breast cancer in Spain is considered the leading cause of death in women and causes 5,000 deaths per year. There are numerous treatments used in this pathology but for the time being, there are none that cure the disease, even so they are used to alleviate or diminish the symptoms that it produces. The most used treatments are Danazol, Bromocriptine and Tamoxifen, although they cause considerable side effects. Objective: to determine the usefulness of the treatments used in premenopausal women with fibrocystic mastopathy. Methodology: a development of an observation process aimed at premenopausal patients who have been diagnosed with MFQ. Implications for the practice of nursing: nursing must obtain more knowledge about this pathology in addition to knowing the most beneficial treatments for patients.
Introduction: Fibrocystic mastopathy is a pathology that is transmitted more and more women in the world and, despite this, is a much unknown disease among them. It is very common between 35-40 years and it consists on the appearance of breast pain (usually associated to the menstrual cycle), nodules in the breast and it can appear breast tension. Depending on the histological characteristics (proliferative lesions with atypia, proliferative lesions without atypia and non-proliferative lesions) there is a higher or lesser risk of developing breast cancer in the future, respectively. Breast cancer in Spain is considered the leading cause of death in women and causes 5,000 deaths per year. There are numerous treatments used in this pathology but for the time being, there are none that cure the disease, even so they are used to alleviate or diminish the symptoms that it produces. The most used treatments are Danazol, Bromocriptine and Tamoxifen, although they cause considerable side effects. Objective: to determine the usefulness of the treatments used in premenopausal women with fibrocystic mastopathy. Methodology: a development of an observation process aimed at premenopausal patients who have been diagnosed with MFQ. Implications for the practice of nursing: nursing must obtain more knowledge about this pathology in addition to knowing the most beneficial treatments for patients.
Información detallada
Materias, derechos, colecciones e identificadores
Keywords
Enfermedad fibroquística de la mama, Premenopausia, Quiste mamario, Enfermedades de la mama, Neoplasias de la mama, Fibrocystic breast disease, Premenopause, Breast cyst, Breast diseases, Breast neoplasms